| http://www.w3.org/ns/prov#value | - PFE???s Failed Bid for AstraZeneca The biggest second-quarter news was PFE???s renewed discussions to acquire British-Swedish pharmaceutical company AstraZeneca Plc. (NYSE ADR: AZN) ??? marketers of such drugs as Crestor, Entocort, and Nexium ??? which were initially rejected in January.
|
